These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20928961)

  • 1. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
    Flack JM
    J Clin Hypertens (Greenwich); 2010 Sep; 12(9):664-5. PubMed ID: 20928961
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
    Bakris GL; Iyengar M; Lukas MA; Ordronneau P; Weber MA
    J Clin Hypertens (Greenwich); 2010 Sep; 12(9):678-86. PubMed ID: 20883227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.
    Saul SM; Duprez DA; Zhong W; Grandits GA; Cohn JN
    J Hum Hypertens; 2013 Jun; 27(6):362-7. PubMed ID: 23190794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and central blood pressure differences between carvedilol and valsartan added to lisinopril at rest and during exercise stress.
    Izzo JL; Rajpal M; Karan S; Srikakarlapudi S; Osmond PJ
    J Am Soc Hypertens; 2012; 6(2):117-23. PubMed ID: 22264722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in mean and variability of heart rate and ambulatory rate-pressure product when valsartan or carvedilol is added to lisinopril.
    Izzo JL; Yedlapati SH; Faheem SM; Younus U; Osmond PJ
    J Am Soc Hypertens; 2012; 6(6):399-404. PubMed ID: 23107894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
    Erdoğan O; Ertem B; Altun A
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol-lisinopril combination therapy and endothelial function in obese individuals with hypertension.
    Kelly AS; Gonzalez-Campoy JM; Rudser KD; Katz H; Metzig AM; Thalin M; Bank AJ
    J Clin Hypertens (Greenwich); 2012 Feb; 14(2):85-91. PubMed ID: 22277140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of carvedilol: a preliminary dose-response study.
    Casadei B; Conway J; Coats AJ; Bird R
    Clin Investig; 1992; 70 Suppl 1():S37-8. PubMed ID: 1350482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
    Juttmann JR; de Vries Robles P; Venuti RP
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
    Weber MA; Bakris GL; Tarka EA; Iyengar M; Fleck R; Sica DA
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12):840-9. PubMed ID: 17170609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative eficacy of antihypertensive therapy in patients with arterial hypertension and various sensitivity to salt].
    Babkin AP; Gladkikh VV; Pershukov IV; Gulaia GI
    Kardiologiia; 2010; 50(10):35-8. PubMed ID: 21118177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol and atenolol once daily in the treatment of hypertension.
    Luurila OJ; Härkönen R; Hilden M; Icen R; Kohvakka A; Linna M; Sillanpää J; Vänskä O; Lukkala K
    J Hypertens Suppl; 1989 Dec; 7(6):S264-5. PubMed ID: 2576666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol in the treatment of mild to moderate hypertension: experience with ambulatory blood pressure monitoring.
    Biston P; Van de Borne P; Mélot C; Smekens P; Marinus W; Degaute JP
    Acta Cardiol; 1994; 49(2):145-55. PubMed ID: 8053282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The once-daily dose regimen of carvedilol: a meta-analysis approach.
    Stienen U
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S128-33. PubMed ID: 1378140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study.
    Ayashi S; Assareh AR; Jalali MT; Olapour S; Yaghooti H
    Indian J Pharmacol; 2016; 48(4):372-376. PubMed ID: 27756946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
    Lund-Johansen P; Omvik P
    Eur Heart J; 1992 Feb; 13(2):281-6. PubMed ID: 1555629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A; Lim C; Duchier J; Safar M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and metabolic effects of carvedilol: a meta-analysis approach.
    Stienen U; Meyer-Sabellek W
    Clin Investig; 1992; 70 Suppl 1():S65-72. PubMed ID: 1350487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol.
    Si D; Wang J; Xu Y; Chen X; Zhang M; Zhou H
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):306-9. PubMed ID: 25291495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.